HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China flag China · Delayed Price · Currency is CNY
9.08
-0.18 (-1.94%)
May 20, 2026, 1:54 PM CST
Market Cap5.37B +26.8%
Revenue (ttm)10.54B +4.1%
Net Income136.46M -24.5%
EPS0.24 -24.5%
Shares Out579.89M
PE Ratio39.35
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,442,700
Average Volume7,121,596
Open9.24
Previous Close9.26
Day's Range9.02 - 9.26
52-Week Range7.12 - 18.13
Beta0.20
RSI33.99
Earnings DateAug 11, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and ren... [Read more]

Sector Healthcare
Founded 1950
Employees 2,735
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600829
Full Company Profile

Financial Performance

In 2025, SHA:600829's revenue was 10.38 billion, an increase of 3.29% compared to the previous year's 10.05 billion. Earnings were 133.84 million, a decrease of -37.24%.

Financial Statements